

ABVC BioPharma said that the licensing agreement includes the ophthalmology pipeline, including the medical device Vitargus licensed products' and clinical...
You can purchase shares of ABVC BioPharma (NASDAQ:ABVC) through any online brokerage.
Other companies in ABVC BioPharma’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
There is no analysis for ABVC BioPharma to provide a consensus price target.
The stock price for ABVC BioPharma (NASDAQ: ABVC) is $0.9819 last updated November 6, 2026 at 4:01 PM EST.
There are no upcoming dividends for ABVC BioPharma.
ABVC BioPharma does not have any upcoming earnings scheduled.
There is no upcoming split for ABVC BioPharma.
ABVC BioPharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes...